The interplay between p53 and p21 tumor suppressor proteins in the transformation of colorectal adenoma to carcinoma

American Journal of Immunology

Volumn 4, Issue 1, 2008, Pages 14-22

  Abdulamir, A S ^a   Hafidh, R R ^a   Mahdi, L K ^b   Al jeboori, T R ^c   Abubaker, F ^a   Abbas, K A ^a  

^a UNIVERSITY PUTRA MALAYSIA   (Malaysia)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c AL NAHRAIN UNIVERSITY   (Iraq)

Author keywords

Adenoma; Colorectal cancer; Ki 67; p21; p53

Indexed keywords

GENE PRODUCT; KI 67 ANTIGEN; PROTEIN P21; PROTEIN P53; TUMOR SUPPRESSOR PROTEIN;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER PATIENT; CANCER STAGING; COLON CARCINOGENESIS; COLORECTAL ADENOMA; COLORECTAL CARCINOMA; CONTROLLED STUDY; CORRELATION FUNCTION; ENZYME ACTIVATION; FEMALE; GENE OVEREXPRESSION; GENETIC ASSOCIATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; PROTEIN DEPLETION; TISSUE SECTION; CANCER GROWTH; CANCER TISSUE; GENE MUTATION; MALIGNANT TRANSFORMATION; MOLECULAR INTERACTION; PATHOPHYSIOLOGY; PROTEIN EXPRESSION;

EID: 54349119539     PISSN: 1553619X     EISSN: None     Source Type: Journal    
DOI: 10.3844/ajisp.2008.14.22     Document Type: Article

References (47)

1. Crawford, J.M. and V. Kumar, 2003. The Oral Cavity and the Gastrointestinal Tract. In: Basic Pathology. Kumar, V., R.S. Cotran and S.L. Robbins (Eds.). 7th Edn., Saunder, Philadelphia and London, pp: 543-590.
2. C.D.C., 2001, Colorectal cancer: The importance of prevention and early detection. http://www.cdc.gov/cancer/colorctl/colopdf/colaag01.pdf. 2001
3. Souza, R.F., 2001. Review article, a molecular rationale for the how, when and why of colorectal cancer screening. Aliment Pharmacol Ther., 15: 451-462.
4. Fearon, E. and B.A. Vogelstein, 1990, Genetic model for colorectal tumorigenesis. Cell, 61: 759-767.
5. Karoui, M., C. Tresallet, A. Brouquet, H. Radvanyi and C. Penna, 2007. Colorectal carcinogenesis: Hereditary predisposition and colorectal cancer. J. Chir., 144: 13-18.
6. Van Stolk, R.U., G.J. Beck, J.A. Baron, R. Haile and R. Summers, 1998. Adenoma characteristics at first colonoscopy as predictors of adenoma recurrence and characteristics at follow-up. Gastroenterology, 115: 13-18.
7. Costantini, M., S. Sciallero, A. Giannini, B. Gatteschi, P. Rinaldi, G. Lanzanova, L. Bonelli, T. Casetti, E. Bertinelli and O. Giuliani, 2003. Interobserver agreement in the histologic diagnosis of colorectal polyps, the experience of the multicenter adenoma colorectal study (SMAC). J. Clin Epiderniol, 56: 209-214.
8. Winawer, S.J., M.J. O'Brien, J.D. Waye, O. Kronborg, J. Bond, P. Fruhmorgen, L.H. Sobin, R. Burt, A. Zauber and B. Morson, 1990. Risk and surveillance of individuals with colorectal polyps: Who collaborating centre for the prevention of colorectal cancer. Bull. World Health Organ., 68: 789-95.
9. Leslie, A., F.A. Carey, N.R. Pratt and R.J. Steele, 2002. The colorectal adenoma-carcinoma sequence. Br. J. Surg., 89: 845-860.
10. Kinzler, K.W. and B. Vogelstein, 1996. Lessons from hereditary colorectal cancer. Cell, 87: 159-170.
11. Bertholon, J., Q. Wang, C.M. Galmarini and A. Puisieux,.2006. Mutational targets in colorectal cancer cells with microsatellite instability. Fam. Cancer, 5: 29-34.
12. Vogelstein, B., E.R. Fearon, S.R. Hamilton, S.E. Kern, A.C. Preisinger and M. Leppert, 1988. Genetic alterations during colorectal tumor development. New England J. Med., 319: 525-532.
13. Baker, S.J., A.C. Preisinger, J.M. Jessup, C. Paraskeva, S. Markowitz, J.K. Willson, S. Hamilton and B. Vogelstein, 1990, P53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis. Cancer Res., 50: 7717-7722.
14. Grady, W.M. and S.D. Markowitz, 2002. Genetic and epigenetic alterations in colon cancer. Annu. Rev. Genomics Hum. Genet., 3: 101-128.
15. Kuerbitz, S.J., B.S. Plunkett, W.V. Walsh and M.B. Kastan, 1992. Wild type p53 is a cell cycle checkpoint determinant following irradiation. Proceed. Natl. Acad. Sci., 93: 4816-4820.
16. Smith, F.M., R.B. Stephens, M.J. Kennedy and J.V. Reynolds, 2005. P53 abnormalities and outcomes in colorectal cancer: A systematic review. Br. J. Cancer, 92: 1813.
17. Kastan, M.B., O. Onyekwere, D. Sidransky, B. Vogelstein and R.W. Craig, 1991. Participation of p53 protein in the cellular response to DNA damage. Cancer Res., 51: 6304-6311.
18. Lane, D.P., 1993. A death in the life of p53. Nature, 362: 786-787.
19. Irby, R.B., W. Mao, D. Coppola, J. Kang, J.M. Loubeau, W. Trudeau, R. Karl, D.I. Fujita, R. Jove and T.J. Yeatman, 1999. Activating SRC mutation in a subset of advanced human colon cancers. Nat. Genet., 21: 187-90.
20. El-Deiry, W.S., T. Tokino, V.E. Velculescu, D.B. Levy, R. Parsons, J.M. Trent, D. Lin, W.E. Mercer, K.W. Kinzler and B. Vogelstein, 1993. Waf1, a potential mediator of p53 tumor suppression. Cell, 75: 817-825.
21. Pines, J., 1994. Protein kinases and cell cycle control. Semin Cell Biol., 5: 399-408.
22. Garner, E. and K. Raj, 2008. Protective mechanisms of p53-p21-pRb proteins against DNA damage-induced cell death. Cell Cycle, 7: 277-282.
23. Van den Heuvel, S., 2005 Cell-Cycle Regulation. Worm Book 1-16.
24. Sherr, C.J., J. Kato, D.E. Quelle, M. Matsuoka and M.F. Roussel, 1994. D-type cyclins and their cyclin-dependent kinases: G1 phase integrators of the mitogenic response. Cold Spring Harb Symp. Quant. Biol., 59: 11-19.
25. Harper, J.W., S.J. Elledge, K. Keyomarsi, B. Dynlacht, L.H. Tsai, P. Zhang, S. Dobrowolski, C. Bai, L. Connell-Crowley and E. Swindell, 1995. Inhibition of cyclin dependent kinases by p21. Mol. Biol. Cell, 6: 387-400.
26. Hiroshi, N., M. Yoshihiko and I. Koji, 2002. Increased proliferative activity caused by loss of p21expression and its clinical significance in patients with early-stage gastric carcinoma. Cancer, 94(7).
27. Van Diest, P., G. Brugal and J.P.A. Baak, 1998 Proliferation markers in tumours: interpretation and clinical value. J. Clin. Pathol., 51: 716-724.
28. Scott, R.J., P.A. Hall and J.S. Haldane, 1991. A comparison of immunohistochemical markers of cell proliferation with experimentally determined growth fraction. J. Pathol., 165: 173-178.
29. Petrowsky, H., I. Sturm, O. Graubitz, D.A. Kooby, E. Staib-Sebler, C. Gog, C.H. Kohne, T. Hillebrand, P.T. Daniel, Y. Fong and M. Lorenz, 2001. Relevance of Ki-67 antigen expression and K-ras mutation in colorectal liver metastases. Eur. J. Surg. Oncol., 27: 80-87.
30. Mattioli, E, P. Vogiatzi, A. Sun, G. Abbadessa, G. Angeloni, D. D'Ugo, D. Trani, J.P. Gaughan, F.M. Vecchio, G. Cevenini, R. Persiani, A. Giordano and P.P. Claudio, 2007. Immunohistochemical analysis of pRb2/ p130, VEGF, EZH2, p53, p16(INK4A), p27(KIP1), p21(WAF1), Ki-67 expression patterns in gastric cancer. J. Cell Physiol., 210: 183-91.
31. Chapusot, C., M. Assem, L. Martin, L. Chalabreyssse, A.M. Benhamiche, M.A. Lignier, B. Chauffert, J.R. Teyssier, J. Faivre and F. Piard, 2001. [Expression of p21 WAF1/CIP1 protein in colorectal cancers: Study of its relation to p53 mutation and Ki67 antigen expression]. Pathol. Biol., 149: 115-123.
32. Pasz-Walczak, G., R. Kordek and M. Faflik, 2001. P21 (WAF1) expression in colorectal cancer: correlation with P53 and cyclin D1 expression, clinicopathological parameters and prognosis. Pathol. Res. Pract., 197: 683-689.
33. Prall, F., C. Ostwald, H. Nizze and M. Barten, 2004. Expression profiling of colorectal carcinomas using tissue microarrays: cell cycle regulatory proteins p21, p27 and p53 as immunohistochemical prognostic markers in univariate and multivariate analysis. Appl. Immunohistochem Mol. Morphol., 12: 111-121.
34. Atsumata, K., T. Sumi, H. Tomioka, T. Aoki and Y. Koyanagi, 2003. Induction of apoptosis by p53, bax, bcl-2 and p21 expressed in colorectal cancer. Int. J. Clin. Oncol., 8: 352-356.
35. Girlando, S., P. Slomp, O. Caffo, M. Amichetti, R. Togni, G. Dvornik, L. Tomio, E. Galligioni, P. Dalla z of tissue sections. J. Histochem Cytochem, 39: 741-748.
36. Marijnen, C.A., E. Kapiteijn, I.D. Nagtegaal, A.A. Mulder-Stapel, C.J. Van de Velde, P.I. Schrier, L.T. Peltenburg and J.H. Van Krieken, 2002. P53 expression in human rectal tissue after radiotherapy: Upregulation in normal mucosa versus functional loss in rectal carcinomas. Int. J. Radiat. Oncol. Biol. Phys., 52: 720-8.
37. Tsoli, E., V.G. Gorgoulis, P. Zacharatos, A. Kotsinas, G. Mariatos, N.G. Kastrinakis, S. Kokotas, P. Kanavaros, P. Asimacopoulos, J. Bramis, D. Kletsas, A.G. Papavassiliou and C. Kittas, 2001. Low levels of p27 in association with deregulated p53-pRb protein status enhance tumor proliferation and chromosomal instability in non-small cell lung carcinomas. Mol. Med., 7: 418-29.
38. Takayama, T., K. Miyanishi, T. Hayashi, Y. Sato and Y. Niitsu, 2006. Colorectal cancer: Genetics of development and metastasis. J. Gastroenterol, 41:185-192.
39. Beroud, C. and T. Soussi, 2003. The UMD-p53 database: new mutations and analysis tools. Hum. Mutat., 21: 176-181.
40. Kikuchi-Yanoshita, R., M. Konishi, S. Ito, M. Seki and K. Tanaka, 1992. Genetic changes of both p53 alleles associated with the conversion from colorectal adenoma to early carcinoma in familial adenomatous polyposis and non-adenomatous polyposis patients. Cancer Res., 52: 3965-3971.
41. Nasierowska-Guttmejer, A., L. Trzeciak, M.P. Nowacki and J. Ostrowski, 2000. P53 protein accumulation and p53 gene mutation in colorectal cancer. Pathol. Oncol. Res., 6: 275-9.
42. Roninson, I.B., E.V. Broude and B.D.Chang, 2001. If not apoptosis, then what? treatment-induced senescence and mitotic catastrophe in tumor cells. Drug Resist Updat,4: 303-313.
43. Morin, N., M. Kelly, N. Barrett and P. Delaney, 1994. Mutations of Ki-ras and p53 genes in colorectal cancer and their prognostic significance. Gut, 35: 1627-1631.
44. Yasui, W., 1999. Expression of cell-cycle-regulating transcription factor E2F-1 in colorectal. carcinomas. Pathobiol., 67: 174-179.
45. Yasui, W., 1997. Expression of p21WAF 1/CIP 1 in colorectal adenomas and adenocarcinomas and its correlation with p53 protein expression. Pathol. Int., 47: 470-477.
46. Knudson, A.G., 1971. Mutation and cancer: Statistical study of retinoblastoma. Proceed. Natl. Acad. Sci. USA, 68: 820-823.
47. Kruger, S. and H. Muller, 1995. Correlation of morphometry, nucleolar organizer regions, proliferating cell nuclear antigen and Ki-67 antigen expression with grading and staging in urinary bladder carcinomas. Br. J. Urol., 75: 480-484.